Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Most pharmaceutical companies should do well. Dr Reddy's Laboratories and Sun Pharmaceutical are affected by news, so we can keep them aside. However, broadly if you are investing Aurobindo Pharma, Lupin, Divis Laboratories all three qualify for investing ideas for three months to six months."At 12:35 hrs Aurobindo Pharma was quoting at Rs 869.40, down Rs 1.85, or 0.21 percent on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
